Announced
Completed
BioAtla completed a $72m Series D funding round.
Synopsis
Soleus Capital, HBM Healthcare, Cormorant Asset, Farallon Capital, Pappas Capital, Janus Henderson, Boxer Capital and Pfizer Ventures invested $72m Series D funding round in BioAtla, a biological service company.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.